NCT07335601Phase 2Recruiting

Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

Study sponsor: Madrigal Pharmaceuticals, Inc. · MDGL

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2028-08Estimated
Enrollment · participants120Estimated
Source updated2026-08-26Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: Jul 2027. After: Aug 2028.

Check registry source

· 1 field changed

Recruitment status changed

Before: Active not recruiting. After: Recruiting.

Check registry source